Navigation Links
DigiPath Labs CSO Dr. Cindy Orser to Speak at the Emerald Scientific Conference in Las Vegas

LAS VEGAS, Jan. 8, 2016 /PRNewswire/ -- Dr. Cindy Orser, the Chief Science Officer of DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP) will be a featured speaker at the Emerald Conference in Las Vegas on Thursday, January 21. Dr. Orser's talk, entitled "Ensuring Patient Safety & Establishing Standardization in Cannabis Testing," is scheduled for 1:30 p.m.

Dr. Orser will cover the evolution of quality assurance testing in the State of Nevada as compared to the rest of the country and the need for standardization of cannabis testing for both recreational and medical cannabis across the United States. Dr. Orser will also unveil DigiPath Labs' plans to partner with a leading organization in linking cannabis chemotypes with genotyping of cannabis strains.

The Emerald Conference is devoted to the exploration and discussion of the science of cannabis including analytical testing, R&D, clinical applications, inter-lab comparison and proficiency testing, state regulations, industry standardization, and more.

"I urge everyone concerned with the future of the cannabis industry to keep their calendars open for this event," commented Dr. Orser. "This conference will present a refreshing perspective."

The event will be held at the Monte Carlo Resort & Casino conference center in Las Vegas, Nevada. The event will draw participants across a wide spectrum of disciplines, including chemists, clinicians, policy makers, cultivators, and dispensary owners. The Emerald Conference aims to share the latest in research and technologies in the cannabis industry in a collegial atmosphere. Tickets are available at

To learn more about DigiPath Labs, visit

About DigiPath, Inc.

DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath's two business units are DigiPath Labs and TNM News Corp.

For more information, go to

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company's products, governmental regulation of the cannabis industry, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.


DigiPath, Inc.
Investor Relations

Logo -


SOURCE DigiPath, Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. DigiPath No New Corporate Developments
2. DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
3. DigiPath Inc. Partners with Blue Line Protection Group to Share Resources and Develop Marketing Initiatives
4. DigiPath Labs Completes First Medical Cannabis Test
5. DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis
6. DigiPath Labs Completes Validation of Romer Labs Food-Borne Pathogen and Mycotoxin Testing Solutions
7. DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing
8. DigiPath, Inc. Appoints Joseph J. Bianco Chairman of the Board
9. DigiPath Labs Offers Insider Observations on the State of Nevadas Medical Cannabis Industry
10. TruHearing Announces Addition of Cindy Dellecker to Advisory Board
11. Douglas Harrington, MD Speaks at American Academy of Physicians Assistants 2013 Conference in Washington, DC
Post Your Comments:
(Date:6/25/2020)... LONDON, CT (PRWEB) , ... June 25, 2020 ... ... yet again on Connecticut Magazine’s 2020 Top Dentist list within the Periodontics category. ... two practice locations in New London, CT and Westerly, RI. Laser gum disease ...
(Date:6/24/2020)... ... June 24, 2020 , ... People curious about chiropractic medicine ... County Line Chiropractic’s YouTube channel. Dr. Vivian Solivan, one of County Line ... locations in the South Florida area, including the Lauderhill office, where Dr. Solivan ...
(Date:6/23/2020)... ... June 23, 2020 , ... Draper today announced the release ... used to test an in vitro human lung model to investigate responses following ... Draper and the University of Massachusetts Medical School . The ...
Breaking Medicine Technology:
(Date:6/28/2020)... Calif. (PRWEB) , ... June 26, 2020 , ... ... tougher. Inland Detox, the Inland Empire’s premier residential addiction treatment center, proudly announces ... services that now includes special preparation for recovery in a world affected by ...
(Date:6/28/2020)... Mass. (PRWEB) , ... June 27, 2020 , ... ... FSHD Connect Classroom, the first online, full-day educational conference in the organization’s history. ... meeting for facioscapulohumeral muscular dystrophy (FSHD), which was cancelled this year due to ...
(Date:6/25/2020)... ... June 25, 2020 , ... Denials Management, Inc. has just ... key steps when filing appeals for denials of mental health and substance use disorder ... individuals about their appeal rights and explain the steps in the appeals process. ...
(Date:6/24/2020)... Ark. (PRWEB) , ... June 24, 2020 , ... Dr. ... program, has been the most requested guest on the True Grit and Grace podcast. ... to have hope and knowing remission is possible. , After being diagnosed with ...
(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... Skyroam ... today a partnership with LabWare , the leading provider of enterprise software for ... WiFi connectivity as part of LabWare’s new Portable Disease Surveillance Lab (PDSL) kit. , ...
Breaking Medicine News(10 mins):